IRLAB Therapeutics' IPO

IRLAB Therapeutics raised a round of funding on March 01, 2017. Investors include Public.

IRLAB Therapeutics is a drug discovery and development company providing novel treatments for disorders of the brain. The company is engaged in programs targeting core dysfunctions in Parkinson's dise…

Articles about IRLAB Therapeutics' IPO: